tadalafil
Generic: tadalafil
Labeler: aphena pharma solutions - tennessee, llcDrug Facts
Product Profile
Brand Name
tadalafil
Generic Name
tadalafil
Labeler
aphena pharma solutions - tennessee, llc
Dosage Form
TABLET
Routes
Active Ingredients
tadalafil 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71610-903
Product ID
71610-903_351dae30-b57e-b988-e063-6394a90a47f2
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210609
Listing Expiration
2026-12-31
Marketing Start
2022-01-18
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71610903
Hyphenated Format
71610-903
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tadalafil (source: ndc)
Generic Name
tadalafil (source: ndc)
Application Number
ANDA210609 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/1
Packaging
- 4 TABLET in 1 BOTTLE (71610-903-04)
- 12 TABLET in 1 BOTTLE (71610-903-12)
- 600 TABLET in 1 BOTTLE (71610-903-31)
- 18 TABLET in 1 BOTTLE (71610-903-52)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "351dae30-b57e-b988-e063-6394a90a47f2", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["402019"], "spl_set_id": ["34684fe8-9bf3-47fd-e063-6394a90ac80f"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "4 TABLET in 1 BOTTLE (71610-903-04)", "package_ndc": "71610-903-04", "marketing_start_date": "20250501"}, {"sample": false, "description": "12 TABLET in 1 BOTTLE (71610-903-12)", "package_ndc": "71610-903-12", "marketing_start_date": "20250501"}, {"sample": false, "description": "600 TABLET in 1 BOTTLE (71610-903-31)", "package_ndc": "71610-903-31", "marketing_start_date": "20250513"}, {"sample": false, "description": "18 TABLET in 1 BOTTLE (71610-903-52)", "package_ndc": "71610-903-52", "marketing_start_date": "20250501"}], "brand_name": "TADALAFIL", "product_id": "71610-903_351dae30-b57e-b988-e063-6394a90a47f2", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "71610-903", "generic_name": "tadalafil", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TADALAFIL", "active_ingredients": [{"name": "TADALAFIL", "strength": "20 mg/1"}], "application_number": "ANDA210609", "marketing_category": "ANDA", "marketing_start_date": "20220118", "listing_expiration_date": "20261231"}